29571-39-9
29571-39-9 structure
- Name: ethyl 2-(4-hydroxy-2-mercaptopyrimidin-5-yl)acetate
- Chemical Name: ethyl 2-(4-oxo-2-sulfanylidene-1H-pyrimidin-5-yl)acetate
- CAS Number: 29571-39-9
- Molecular Formula: C8H10N2O3S
- Molecular Weight: 214.24200
- Catalog: Pharmaceutical intermediate Heterocyclic compound Pyrimidine compound Mercaptopyrimidine
- Create Date: 2018-12-27 19:07:18
- Modify Date: 2024-01-10 19:45:19
| Name | ethyl 2-(4-oxo-2-sulfanylidene-1H-pyrimidin-5-yl)acetate |
|---|---|
| Synonyms |
5-ethoxycarbonylmethylene-2-thiouracil
5-ethoxycarbonylmethyl-2-thiouracil 2-Thio-5-ethoxycarbonylmethyl-uracil |
| Density | 1.36g/cm3 |
|---|---|
| Melting Point | 179-180℃ |
| Molecular Formula | C8H10N2O3S |
| Molecular Weight | 214.24200 |
| Exact Mass | 214.04100 |
| PSA | 107.04000 |
| LogP | 0.53810 |
| Index of Refraction | 1.592 |
| HS Code | 2933599090 |
|---|
|
~38%
29571-39-9 |
| Literature: ISIS Pharmaceuticals, Inc.; PepSeptive Biosystems, Inc. Patent: US6441130 B1, 2002 ; Title/Abstract Full Text Show Details ISIS Pharmaceuticals, Inc.; Perseptive Biosystems, Inc. Patent: US6451968 B1, 2002 ; |
|
~%
29571-39-9 |
| Literature: CANCER THERAPEUTICS CRC PTY LTD; DEVLIN, Mark Graeme; STREET, Ian Philip; TONG, Warwick Bonner Patent: WO2014/27199 A1, 2014 ; Location in patent: Page/Page column 133 ; |
|
~%
29571-39-9 |
| Literature: Johnson Journal of the American Chemical Society, 1911 , vol. 33, p. 762 |
|
~%
29571-39-9 |
| Literature: CANCER THERAPEUTICS CRC PTY LTD; DEVLIN, Mark Graeme; STREET, Ian Philip; TONG, Warwick Bonner Patent: WO2014/27199 A1, 2014 ; |
| Precursor 3 | |
|---|---|
| DownStream 3 | |
| HS Code | 2933599090 |
|---|---|
| Summary | 2933599090. other compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |